1. ALLA AKTIER
  2. NYHETER
  3. SPAGO NANOMEDICAL

Spago Nanomedical

Nyheter Spago Nanomedical Nyheter alla bolag

Spago Nanomedical publishes the annual report for 2022

MARKN.

Spago Nanomedical's annual report for 2022 is from today available at the company’s website, https://spagonanomedical.se/investor-relations/#financial-reports

For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, mats.hansen@spagonanomedical.se

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases. Spago Nanomedical´s share is listed on Nasdaq First North Growth Market (ticker: SPAGO). For further information, see www.spagonanomedical.se.

FNCA Sweden AB is the Certified Adviser of the company.

Attachments

Annual Report 2022

Datum 2023-03-29, kl 13:03
Källa MFN
Bifogade filer
Annual Report 2022
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!